Related Experiment Video
Updated: Aug 20, 2025

Organoid-Derived Epithelial Monolayer: A Clinically Relevant In Vitro Model for Intestinal Barrier Function
Published on: July 29, 2021
The genetics of monogenic intestinal epithelial disorders
Stephen J Babcock1, David Flores-Marin1, Jay R Thiagarajah2
1Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Harvard Medical School, Enders Rm 605, 300 Longwood Ave, Boston, MA, 02115, USA.
Insights
Congenital diarrheas and enteropathies (CoDEs) are rare genetic disorders affecting intestinal cells. While over 45 genes are linked, understanding pathophysiology and developing targeted therapies remain critical challenges.
Area of Science:
- Gastroenterology
- Genetics
- Pediatrics
Background:
- Monogenic intestinal epithelial disorders, or congenital diarrheas and enteropathies (CoDEs), are rare genetic conditions impacting intestinal epithelial cell function.
- These disorders typically manifest in infancy with diarrhea and poor growth, necessitating intensive supportive care.
- Over 45 genes are now implicated, highlighting rapid advancements in genetic discovery.
Purpose of the Study:
- To provide a comprehensive overview of CoDE disorders, encompassing their history, genetics, and clinical presentations.
- To elucidate the known pathophysiology of specific CoDE disorders.
- To identify current challenges and future directions in the genetic and therapeutic landscape of CoDEs.
Main Methods:
- Literature review of monogenic intestinal epithelial disorders.
- Synthesis of information on genetics, clinical features, and pathophysiology.
- Analysis of current management limitations and future research needs.
Main Results:
- CoDE disorders are classified based on affected epithelial functions, structures, or development.
- Genetic sequencing has identified over 45 causative genes, but cellular pathophysiology is often poorly understood.
- Limited therapeutic options exist, underscoring the need for disorder-specific treatments.
Conclusions:
- Despite genetic advances, a significant knowledge gap exists in understanding CoDE pathophysiology.
- Urgent need for novel, targeted therapies for these rare intestinal disorders.
- Future research should focus on elucidating cellular mechanisms to enable effective treatment development.
Abstract:
Monogenic intestinal epithelial disorders, also known as congenital diarrheas and enteropathies (CoDEs), are a group of rare diseases that result from mutations in genes that primarily affect intestinal epithelial cell function. Patients with CoDE disorders generally present with infantile-onset diarrhea and poor growth, and often require intensive fluid and nutritional management. CoDE disorders can be classified into several categories that relate to broad areas of epithelial function, structure, and development. The advent of accessible and low-cost genetic sequencing has accelerated discovery in the field with over 45 different genes now associated with CoDE disorders. Despite this increasing knowledge in the causal genetics of disease, the underlying cellular pathophysiology remains incompletely understood for many disorders. Consequently, clinical management options for CoDE disorders are currently limited and there is an urgent need for new and disorder-specific therapies. In this review, we provide a general overview of CoDE disorders, including a historical perspective of the field and relationship to other monogenic disorders of the intestine. We describe the genetics, clinical presentation, and known pathophysiology for specific disorders. Lastly, we describe the major challenges relating to CoDE disorders, briefly outline key areas that need further study, and provide a perspective on the future genetic and therapeutic landscape.
Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Renewal of Intestinal Stem Cells
Pleiotropy
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Sex-linked Disorders

